U-69593
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


U-69593
Description:
U-69593 is a potent and selective κ1-opioid receptor agonist[1]. U-69593 attenuates addictive agent-induced behavioral sensitization in the rat[2]. U-69593 reduces anxiety and enhances spontaneous alternation memory in mice[3]. U-69593 reduces calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum[4].UNSPSC:
12352005Target:
Opioid ReceptorType:
Reference compoundRelated Pathways:
GPCR/G Protein; Neuronal SignalingApplications:
Neuroscience-NeuromodulationField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/u-69593.htmlPurity:
99.73Solubility:
DMSO : 50 mg/mL (ultrasonic)Smiles:
CN ([C@@H]1[C@] (N2CCCC2) ([H]) C[C@]3 (CCCO3) CC1) C (CC4=CC=CC=C4) =OMolecular Formula:
C22H32N2O2Molecular Weight:
356.50References & Citations:
[1]Lahti RA, et al. [3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol. 1985 Feb 26;109 (2) :281-4. |[2][2]Heidbreder CA, et al. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 1993 Jul 9;616 (1-2) :335-8.|[3][3]Wall PM, et al. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice. Brain Res. 2000 Feb 21;856 (1-2) :259-80.|[4][4]Gray AM, et al. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J Neurochem. 1999 Sep;73 (3) :1066-74.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
κ Opioid Receptor/KORCAS Number:
96744-75-1
